Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576394 · ClinicalTrials.gov registry record · Phase 1
Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients
A Phase 1 study, sponsored by American Heart Association.
- Completed
- Registry status
- Phase 1
- Development phase
- 108
- Enrollment target
NCT00576394: Completed Phase 1 study, sponsored by American Heart Association.
NCT00576394 is a Phase 1 study that has completed, run by American Heart Association. The registered enrollment target is 108 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00576394, a Phase 1 study, has completed, sponsored by American Heart Association.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 108 participants
- Enrollment target
Study Summary
entGlycemic control has been found to improve clinical outcomes following Coronary Bypass Surgery. This study tests the hypothesis that obtaining tighter glycemic control(80-120mg/dl) as opposed to more moderate control (120-180mg/dl) will further improve outcomes.
Interventions
- DRUG Insulin
- DRUG IV Insulin drip
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2006-10 |
| Est. Completion | 2015-06 |
| Phase | Phase 1 |
What the finished NCT00576394 record still lists
NCT00576394 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% higher).
The record links to 0 conditions, and to 2 interventions - of which Insulin is the first listed.
NCT00576394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00576394 about?
NCT00576394 is a clinical study titled "Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients". entGlycemic control has been found to improve clinical outcomes following Coronary Bypass Surgery. This study tests the hypothesis that obtaining tighter glycemic control(80-120mg/dl) as opposed to more moderate control (120-180mg/dl) will further improve outcomes.
What is the current status of trial NCT00576394?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 108 participants. The study started on 2006-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT00576394?
The interventions under investigation include: Insulin (DRUG), IV Insulin drip (DRUG).
Who is sponsoring clinical trial NCT00576394?
This trial is sponsored by American Heart Association, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00576394's enrollment target sits among peer trials
108 523rd of 2000 higher than 1,470 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia